WATER FOR INJECTION FROM REVERSE OSMOSIS + UF

CROS Sanitary Reverse Osmosis

PRODUCING “COLD” WATER FOR INJECTION w/ RO SYSTEMS

Is there safety in the production of WFI by Reverse Osmosis? BRAM-COR is committed to providing a clear answer to every need of water treatment to produce pharmaceutical waters (i.e. PW or WFI) or at least critical applications (cosmetics, healthcare, human food and animal feed, for example). So, our approach is really focused, with a wide range of specific knowledge.

What “pure” water means

We believe that every pharmaceutical facility needs “pure” water. First of all, the question is: what this word, “pure”, means? In order to answer this question, it is necessary to go back to the source and analyse  the quality of the water in-situ (the raw water used), which varies greatly from place to place. Then, the task of the pre-treatment of water is just that: bring the particular water to a functional quality, according to the user requirements specification (URS).
Subsequently, the quality of the water must meet the required pharmacopoeia quality levels if it is to be used, for example, in the production of water for injection (infusion bags or bottles, etc.).
Water treatment systems are designed to ensure a consistent quality of water production, including through physical systems such as reverse osmosis. However, the production of WFI from reverse osmosis systems requires special attention, as in RO there is no change in the state of the water (from liquid to vapour, a natural microbiological barrier).

Sanitary Reverse-Osmosis-system

“Cold” WFI from RO requires Ultrafiltration (UF)

In WFI production, unklike distillation, the RO system requires a proper downstream unit to prevent contaminations: the ultrafiltration (UF). This is the only know system that allows process validation. Naturally, it must be done a continuous control on RO efficiency, in terms of membrane degradation, biofilm prevention and microbial charges, with periodic sanitization. If there are no obstacles in ensuring this constant monitoring, the reverse osmosis system can offer a real advantage, reducing the energy needs and thus reducing production costs.

RO and Water Pretreatment Systems

As mentioned above, any pharmaceutical water pretreatment system must be customized after a thorough evaluation of feedwater quality using the customer’s water analysis. The raw water must be pre-treated to remove contaminants (such as particulates, calcium and magnesium salts, heavy metals, organics and bacteria) through a multiplicity of different steps (they  can include softeners, UV reactors, deionizers, …)

Ultraviolet light is employed as a bactericide and to break down organic contaminants. The UV source has a wavelength of 240-260 nm (UV-C) to achieve a absolute reduction of typical pathogenic contaminants.

Chemical dosing stations are added for many purposes such as water disinfection and/or chlorine neutralization. Pre-treated water quality is constantly monitored to ensure suitability to feed downstream water treatment equipments, such as the RO units to produce WFI.

BRAM-COR performs accurate simulations starting from raw water data to design and tailor the best suitable Pretreatment Plants for any specific condition. For an effective microbial control strategy to prevent biofilm formation and fight against severe contaminations by pseudomonas aeruginosa, BRAM-COR designs and supplies hot water sanitizable versions.

Further information about BRAM-COR Sanitary Reverse Osmosis systems: pharmaceutical-reverse-osmosis-systems.com 

You  can enlarge and/or rotate the 3D image